drugset / Trial / NCT05085782

Reconsolidation Therapy With Propranolol as a Treatment for Chronic Pain

NCT05085782

Phase 2 Completed 48 enrolled University of Sherbrooke
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary aim of this study is to document the feasibility and acceptability of an intervention consisting of pain neuroscience education and reconsolidation therapy with propranolol in adults suffering from chronic pain (chronic low back pain or fibromyalgia). The secondary aim of the study is to estimate the effect size of the intervention on pain and function one month post-intervention, and to obtain data for sample-size calculation for a subsequent randomized controlled trial.

Timeline

Start
2022-02-07
Primary completion
2024-12-30
Completion
2025-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Propranolol Small molecule 40 mg Oral
Subject Propranolol Small molecule 80 mg Oral

Indications